A smart drug delivery system (or targeted drug delivery system) is a method in which medication administered to a patient is concentrated more on some parts of the body than others. In conventional drug delivery systems, the drug is distributed throughout the human body via the blood stream. The disadvantage of this system is that only a small portion of the drug reaches the unhealthy organ or tissues. It can also cause side effects by affecting other healthy tissues.
Smart drug delivery seeks to prevent all such issues by increasing the drug concentration on diseased tissues while reducing side effects. Their advantages include increased treatment efficacy, increased specific localization, decreased toxic side effects, reduced dosage, improved patient compliance, and controlled bio distribution.
The advanced and targeted drug delivery market is expected to grow from its 2016 figure of US $168 billion to US $319 billion, clocking a CAGR of 10.4%. In comparison, the global drug delivery system market was US $510 billion in 2016 and is expected to surpass US $900 billion by 2025 – with a CAGR of 6.9%. This IP landscape report provides insights into the patents addressing the technologies and applications related to smart drug delivery systems.
